These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 33946649)

  • 1. ACE2 Is an Adjacent Element of Atherosclerosis and COVID-19 Pathogenesis.
    Poznyak AV; Bezsonov EE; Eid AH; Popkova TV; Nedosugova LV; Starodubova AV; Orekhov AN
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACE2 and energy metabolism: the connection between COVID-19 and chronic metabolic disorders.
    Cao X; Song LN; Yang JK
    Clin Sci (Lond); 2021 Feb; 135(3):535-554. PubMed ID: 33533405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecules in pathogenesis: angiotensin converting enzyme 2 (ACE2).
    Wiese O; Zemlin AE; Pillay TS
    J Clin Pathol; 2021 May; 74(5):285-290. PubMed ID: 32759311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACE2: from protection of liver disease to propagation of COVID-19.
    Warner FJ; Rajapaksha H; Shackel N; Herath CB
    Clin Sci (Lond); 2020 Dec; 134(23):3137-3158. PubMed ID: 33284956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Roles of the Renin-Angiotensin System in the Pathogenesis and Treatment of COVID-19.
    Lu L; Liu X; Jin R; Guan R; Lin R; Qu Z
    Biomed Res Int; 2020; 2020():7520746. PubMed ID: 33204713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pressor dose of angiotensin II has no influence on the angiotensin-converting enzyme 2 and other molecules associated with SARS-CoV-2 infection in mice.
    Wang Y; Takeshita H; Yamamoto K; Huang Y; Wang C; Nakajima T; Nozato Y; Fujimoto T; Yokoyama S; Hongyo K; Nakagami F; Akasaka H; Takami Y; Takeya Y; Sugimoto K; Rakugi H
    FASEB J; 2021 Mar; 35(3):e21419. PubMed ID: 33566370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACE2 role in SARS-CoV-2 infectivity and Covid-19 severity.
    Azizan E; Brown M
    Malays J Pathol; 2020 Dec; 42(3):363-367. PubMed ID: 33361716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathways triggered by COVID-19 in different organs: ACE2 receptor-expressing cells under attack? A review.
    Saba L; Gerosa C; Fanni D; Marongiu F; La Nasa G; Caocci G; Barcellona D; Balestrieri A; Coghe F; Orru G; Coni P; Piras M; Ledda F; Suri JS; Ronchi A; D'Andrea F; Cau R; Castagnola M; Faa G
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12609-12622. PubMed ID: 33336781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Origin and genomic characteristics of SARS-CoV-2 and its interaction with angiotensin converting enzyme type 2 receptors, focusing on the gastrointestinal tract.
    Galanopoulos M; Doukatas A; Gazouli M
    World J Gastroenterol; 2020 Nov; 26(41):6335-6345. PubMed ID: 33244196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of angiotensin-converting enzyme 2 in neurodegenerative diseases during the COVID-19 pandemic.
    Li Z; Xu X; Yang M; Feng J; Liu C; Yang C
    Aging (Albany NY); 2020 Nov; 12(23):24453-24461. PubMed ID: 33197881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin System.
    Edmonston DL; South AM; Sparks MA; Cohen JB
    Adv Chronic Kidney Dis; 2020 Sep; 27(5):404-411. PubMed ID: 33308506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACE2: Its potential role and regulation in severe acute respiratory syndrome and COVID-19.
    Rezaei M; Ziai SA; Fakhri S; Pouriran R
    J Cell Physiol; 2021 Apr; 236(4):2430-2442. PubMed ID: 32901940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cardiovascular disorders and prognostic cardiac biomarkers in COVID-19.
    Shi X; Chen M; Zhang Y
    Mol Biol Rep; 2021 Feb; 48(2):1763-1771. PubMed ID: 33483864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2/human interactome reveals ACE2 locus crosstalk with the immune regulatory network in the host.
    Lite C; Ahmed SSSJ; Juliet M; Freddy AJ
    Pathog Dis; 2021 Feb; 79(2):. PubMed ID: 33469663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of ACE inhibitors and angiotensin type II blockers with ACE2 overexpression in COVID-19 comorbidities: A pathway-based analytical study.
    Parit R; Jayavel S
    Eur J Pharmacol; 2021 Apr; 896():173899. PubMed ID: 33508281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of the Renin-Angiotensin-Aldosterone System (RAA) in Patients Infected with SARS-CoV-2-Possible Clinical Consequences.
    Dettlaff-Pokora A; Swierczynski J
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in COVID-19: candidate pathways, genetics of ACE2, and sex hormones.
    Viveiros A; Rasmuson J; Vu J; Mulvagh SL; Yip CYY; Norris CM; Oudit GY
    Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H296-H304. PubMed ID: 33275517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACE2 and SARS-CoV-2: Tissue or Plasma, Good or Bad?
    Wenzel UO; Kintscher U
    Am J Hypertens; 2021 Apr; 34(3):274-277. PubMed ID: 33151267
    [No Abstract]   [Full Text] [Related]  

  • 19. Angiotensin-converting enzyme 2 and kidney diseases in the era of coronavirus disease 2019.
    Suh SH; Ma SK; Kim SW; Bae EH
    Korean J Intern Med; 2021 Mar; 36(2):247-262. PubMed ID: 33617712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-cell RNA sequencing analysis of human kidney reveals the presence of ACE2 receptor: A potential pathway of COVID-19 infection.
    He Q; Mok TN; Yun L; He C; Li J; Pan J
    Mol Genet Genomic Med; 2020 Oct; 8(10):e1442. PubMed ID: 32744436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.